J Dent Anesth Pain Med.  2017 Jun;17(2):113-119. 10.17245/jdapm.2017.17.2.113.

Distribution of medical status and medications in elderly patients treated with dental implant surgery covered by national healthcare insurance in Korea

• Lee K
• Dam C
• Huh J
• Park KM
• Kim SY
• Park W

• KMID: 2384472
• DOI: http://doi.org/10.17245/jdapm.2017.17.2.113

Abstract

BACKGROUND
The purpose of this study was to investigate the distribution of systemic diseases and medications in patients older than 65 years of age who visited the hospital for implant treatment, as well as to investigate basic information about surgical complications that may occur after insured implant treatment.
METHODS
A total of 126 patients over 65 years of age were treated for implant surgery from October 1, 2013 to October 30, 2016. Electronic chart review was conducted to obtain medical records, which included sex, age, systemic diseases, medication(s) being taken, and control of the medications. Five patients were excluded due to lack of medical records giving information about systemic disease.
RESULTS
Of the 126 patients, 112 (88.9%) were taking medication due to systemic disease and 9 patients (7.1%) were not. The sex distribution was 71 women and 55 men and the highest proportion of patients were between 65 and 69 years old. The most common diseases were, from most to least frequent, hypertension, cardiovascular disease, diabetes, and osteoporosis. The drug groups that can cause major complications after dental treatment were classified as hemorrhagic, osteoporotic, and immunosuppressive agents, and were taken by 45 (35.7%), 22 (17.5%) and 4 (3.2%) patients, respectively.
CONCLUSION
Given that 88.9% of the elderly patients who were eligible for insurance implant treatment had systemic disease, it is necessary to carefully evaluate patients' medical histories and their general conditions in order to prevent emergencies during implant surgery.

Keyword

Aged; Dental Implants; Medical History Taking; National Health Programs; Postoperative Complications

MeSH Terms

Aged*
Cardiovascular Diseases
Delivery of Health Care*
Dental Implants*
Emergencies
Female
Humans
Hypertension
Immunosuppressive Agents
Insurance*
Korea*
Male
Medical History Taking
Medical Records
National Health Programs
Osteoporosis
Postoperative Complications
Sex Distribution
Dental Implants
Immunosuppressive Agents

Figure

• 

  Fig. 1 Age and Sex distribution.

Reference

1. Manor Y, Simon R, Haim D, Garfunkel A, Moses O. Dental implants in medically complex patients—a retrospective study. Clin Oral Investig. 2017; 21:701–708.

2. Woo HK, Shin EJ, Lim JM, Lee HS, Kim HS. Drug use review, analysis, and adequacy assessment of elderly outpatients. J Korean Soc Health Syst Pharm. 2014; 31:983–991.

3. Goodacre CJ, Bernal G, Rungcharassaeng K, Kan JY. Clinical complications with implants and implant prostheses. J Prosthet Dent. 2003; 90:121–132.

4. Zarb GA, Schmitt A. Implant therapy alternatives for geriatric edentulous patients. Gerodontology. 1993; 10:28–32.

5. Diz P, Scully C, Sanz M. Dental implants in the medically compromised patient. J Dent. 2013; 41:195–206.

6. Doonquah L, Mitchell AD. Oral surgery for patients on anticoagulant therapy: Current thoughts on patient management. Dent Clin North Am. 2012; 56:25–41.

7. Hirsh J, Levine M. Low molecular weight heparin. Blood. 1992; 79:1–17.

8. Hellstein JW, Adler RA, Edwards B, Jacobsen PL, Kalmar JR, Koka S, et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the american dental association council on scientific affairs. J Am Dent Assoc. 2011; 142:1243–1251.

9. Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: Different mechanisms of action and effects. Bone. 2011; 48:677–692.

10. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014; 72:1938–1956.

11. Food and Drug Administration. Background document for meeting of advisory committee for reproductive health drugs and drug safety and risk management advisory committee. Center for Drug Evaluation and Research;2011. p. 17–20.

12. Guggenheimer J, Eghtesad B, Stock DJ. Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95:383–389.